Expression of ezrin in oral squamous cell carcinoma: Prognostic impact and clinicopathological correlations

Blessmann, 2013, Amplification of the PPFIA1 gene region on 11q13 in oral squamous cell carcinomas (OSCC), J Craniomaxillofac Surg, 41, 845, 10.1016/j.jcms.2013.01.040 Bloebaum, 2014, Survival after curative surgical treatment for primary oral squamous cell carcinoma, J Craniomaxillofac Surg, 42, 1572, 10.1016/j.jcms.2014.01.046 Bonilha, 2007, Focus on molecules: ezrin, Exp Eye Res, 84, 613, 10.1016/j.exer.2006.01.011 Bretscher, 2002, ERM proteins and merlin: integrators at the cell cortex, Nat Rev Mol Cell Biol, 3, 586, 10.1038/nrm882 Burke, 2004, Outcome prediction and the future of the TNM staging system, J Natl Cancer Inst, 96, 1408, 10.1093/jnci/djh293 Cox, 1972, Regression model and life-tables, J R Stat Soc, 34, 187 Curto, 2008, Nf2/Merlin: a coordinator of receptor signalling and intercellular contact, Br J Cancer, 98, 256, 10.1038/sj.bjc.6604002 Eckert, 2012, Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients, Oral Maxillofac Surg, 16, 189, 10.1007/s10006-012-0335-8 Fazioli, 1993, The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation, Oncogene, 8, 1335 Fehon, 2010, Organizing the cell cortex: the role of ERM proteins, Nat Rev Mol Cell Biol, 11, 276, 10.1038/nrm2866 Feller, 2012, New 'second primary' cancers, SADJ, 67, 175 Gunn-Moore, 2005, A novel 4.1 ezrin radixin moesin (FERM)-containing protein,‘Willin’, FEBS lett, 579, 5089, 10.1016/j.febslet.2005.07.097 Hunter, 2004, Ezrin, a key component in tumor metastasis, Trends Mol Med, 10, 201, 10.1016/j.molmed.2004.03.001 Jemal, 2009, Cancer statistics, 2009, CA Cancer J Clin, 59, 225, 10.3322/caac.20006 Kaplan, 1958, Non-parametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Kapoor, 2013, Ezrin and its emerging role in tumor progression in systemic malignancies, Cryobiology, 66, 93, 10.1016/j.cryobiol.2012.11.009 Kobayashi, 2003, Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma, J Oral Pathol Med, 32, 344, 10.1034/j.1600-0714.2003.00111.x Kreppel, 2013, The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery, J Craniomaxillofac Surg, 41, 22, 10.1016/j.jcms.2012.05.005 Lothaire, 2006, Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation, Head Neck, 28, 256, 10.1002/hed.20326 Madan, 2006, Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma, Head Neck, 28, 1018, 10.1002/hed.20435 Mangeat, 1999, ERM proteins in cell adhesion and membrane dynamics: Authors' correction, Trends Cell Biol, 9, 289, 10.1016/S0962-8924(99)01607-4 Morandi, 2015, Clonality analysis in primary oral squamous cell carcinoma and related lymph-node metastasis revealed by TP53 and mitochondrial DNA next generation sequencing analysis, J Craniomaxillofac Surg, 43, 208, 10.1016/j.jcms.2014.11.007 Ohtani, 1999, Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells, Cancer Lett, 147, 31, 10.1016/S0304-3835(99)00272-4 Oliveira, 2011, Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma, Int J Oral Maxillofac Surg, 40, 298, 10.1016/j.ijom.2010.12.003 Patara, 2011, Ezrin expression as a prognostic marker in colorectal adenocarcinoma, Pathol Oncol Res, 17, 827, 10.1007/s12253-011-9389-4 Renkonen, 2002, Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions, Virchows Arch, 440, 594, 10.1007/s00428-002-0616-y Saito, 2013, Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma, PLoS One, 8, e54881, 10.1371/journal.pone.0054881 Schlecht, 2012, Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma, Head Neck Pathol, 6, 232, 10.1007/s12105-011-0328-1 Schliephake, 2003, Prognostic relevance of molecular markers of oral cancer–a review, Int J Oral Maxillofac Surg, 32, 233, 10.1054/ijom.2002.0383 Shi, 2014, Prognostic factors and survival rates for parotid duct carcinoma patients, J Craniomaxillofac Surg, 42, 1929, 10.1016/j.jcms.2014.08.001 Sleeman, 2010, Cancer metastasis as a therapeutic target, Eur J Cancer, 46, 1177, 10.1016/j.ejca.2010.02.039 Sobin, 2010 Tokunou, 2000, Altered expression of the ERM proteins in lung adenocarcinoma, Lab Invest, 80, 1643, 10.1038/labinvest.3780174 Vormittag, 2009, Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy, Int J Radiat Oncol Biol Phys, 73, 913, 10.1016/j.ijrobp.2008.10.040 Zeng, 2006, Altered expression of ezrin in esophageal squamous cell carcinoma, J Histochem Cytochem, 54, 889, 10.1369/jhc.5A6881.2006